The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
ti ge rui luo yu a si pi lin dui dong mai zhou yang ying hua yin qi de zu zhong huo duan zan xing nao que xue fa zuo de liao xiao he an quan xing bi jiao
Pages: 337
Year: Issue:  4
Journal: International Journal of Cerebrovascular Diseases

Abstract: 替格瑞洛(ticagrelor)是用于冠状动脉粥样硬化疾病患者的一种有效抗血小板药.对于动脉粥样硬化引起的急性脑缺血患者,其在预防复发性卒中和心血管事件方面可能比阿司匹林更有效.法国巴黎比沙特大学医院神经内科和卒中中心的Amarenco等对阿司匹林或替格瑞洛治疗急性卒中或短暂性缺血性发作和患者转归(Acute Stroke or Transient Ischaemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes, SOCRATES)试验进行了一项亚组分析,旨在评价治疗药物与同侧动脉粥样硬化性狭窄的相互作用.
Related Articles
No related articles found